Quick Answer
Journey Medical Corp reported Long-Term Debt of $25.28 million for fiscal year 2025.
Journey Medical Corp Long-Term Debt — Annual History
| Fiscal Year | Long-Term Debt | YoY Change |
|---|---|---|
| 2025 | $25.28M | +1.6% |
| 2024 | $24.88M | +70.1% |
| 2023 | $14.62M | -26.2% |
| 2022 | $19.83M | — |
Quarterly Long-Term Debt
| Quarter Ending | Long-Term Debt | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $19.53M | -1.3% | -8.6% |
| June 30, 2025 | $21.36M | +8.2% | -7.5% |
| March 31, 2025 | $23.11M | +57.3% | -7.1% |
| December 31, 2024 | $24.88M | +70.1% | +25.7% |
| September 30, 2024 | $19.79M | — | +0.2% |
| June 30, 2024 | $19.75M | — | +34.5% |
| March 31, 2024 | $14.68M | +47.9% | +0.4% |
| December 31, 2023 | $14.62M | -26.2% | +47.3% |
- Journey Medical Corp showed an increase of +1.6% in Long-Term Debt compared to the prior fiscal year.
- Over the 2022–2025 period, Journey Medical Corp’s long-term debt has grown by 27.5% (from $19.83 million to $25.28 million).
- The most recent figure is from Journey Medical Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: